Discontinuation report DEPO-MEDROL WITH LIDOCAINE

Last updated on 2018-10-16 History
Report ID 64425
Drug Identification Number 00260428
Brand name DEPO-MEDROL WITH LIDOCAINE
Common or Proper name Depo-Medrol + Lidocaine
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE METHYLPREDNISOLONE ACETATE
Strength(s) 10MG 40MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRABURSAL
Packaging size 1x1ml
ATC code H02BX
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-10-15
Remaining supply date 2018-10-15
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Format replaced by Depo-Medrol+Lidocaine 40mg/ml 1x2ml.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-16 French Compare
v1 2018-10-16 English Compare

Showing 1 to 2 of 2